1. Home
  2. WAVE vs TENX Comparison

WAVE vs TENX Comparison

Compare WAVE & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eco Wave Power Global AB (publ)

WAVE

Eco Wave Power Global AB (publ)

N/A

Current Price

$5.28

Market Cap

47.5M

Sector

Utilities

ML Signal

N/A

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$1.39

Market Cap

74.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WAVE
TENX
Founded
2011
1967
Country
Israel
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.5M
74.1M
IPO Year
2021
2001

Fundamental Metrics

Financial Performance
Metric
WAVE
TENX
Price
$5.28
$1.39
Analyst Decision
Buy
Buy
Analyst Count
2
10
Target Price
★ $14.75
$12.56
AVG Volume (30 Days)
7.8K
★ 2.2M
Earning Date
11-16-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$360.53
N/A
Revenue Next Year
$42.86
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.52
$1.31
52 Week High
$10.87
$19.40

Technical Indicators

Market Signals
Indicator
WAVE
TENX
Relative Strength Index (RSI) 36.31 22.56
Support Level $4.54 $1.31
Resistance Level $5.50 $2.00
Average True Range (ATR) 0.28 0.10
MACD -0.03 0.07
Stochastic Oscillator 12.77 0.00

Price Performance

Historical Comparison
WAVE
TENX

About WAVE Eco Wave Power Global AB (publ)

Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient wave energy conversion, or WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographically, it has a presence in Israel, the USA, and Mexico.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a phase three, development-stage pharmaceutical company focused on identifying and developing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with an initial therapeutic focus on pulmonary hypertension. Its drug development pipeline comprises: Levosimendan, a novel, first-in-class K-ATP activator and calcium sensitizer developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and Imatinib, as a potential therapy for pulmonary arterial hypertension. The company is currently conducting clinical trials only for levosimendan as its prioritized product candidate to evaluate its potential to help patients with pulmonary hypertension.

Share on Social Networks: